Funding · 29 September 2022Redcliffe Labs$100-125 millionDiagnostic healthcare and pathology testsredcliffelabs.com ↗
FundingHealthcare & Life Sciences
Redcliffe Labs plans to raise $100-125 million
By Abha Lohia · Editor ·
Redcliffe Labs: revenue and funding and every story →
Series B
- Redcliffe Labs is a diagnostic healthcare company offering pathology and lab tests
- It is in early stages of raising $100-125 million, four months after a $61 million Series B
- The funds will expand its lab network from 38 to 200 labs by March 2024, focusing on smaller towns
What happened
- Redcliffe Labs is in the early stages of raising $100-125 million.
- The company raised $61 million in a Series B round about four months earlier, in May 2022.
- Founder Dheeraj Jain is quoted in the article about the plans.
- The company currently operates 38 labs.
- It aims to reach 100 labs by March 2023, adding about 10 labs per month.
- It then plans to add another 100 labs by March 2024.
- Expansion will focus on Tier 2, 3, and 4 towns and cities.
Why it matters
- The company is expanding aggressively in south India, opening a regional lab in Tamil Nadu and planning a large lab in Bengaluru.
- It is in acquisition talks with a player in Tamil Nadu covering Madurai and Salem.
- It plans to set up 50 collection centres each in Tamil Nadu and Karnataka between January and March 2023.
- The south is the biggest market for specialised testing, which Redcliffe Labs is entering.
The business
- Redcliffe Labs is a diagnostic healthcare player offering pathology and diagnostic tests.
- It has touched over 1 crore lives and operates 80+ self-owned certified labs.
- It has 2,000+ collection centres and 1,500+ trained phlebotomists.
- Services include health checkup packages, full body fever, heart, vitamin, diabetes, thyroid, hormones, lifestyle, cancer, combo, pregnancy, allergy, STD, anemia, antenatal, GeneCliffe, HealthEx, and Femcliffe (a she-centric diagnostic platform).
- Features include one-prick sample collection at home, temperature-controlled sample transport, MD pathologist-verified reports, smart reports with colour-coded insights, expert consultation, AI assistance 24/7, and a diet plan.
- It offers a 100% report accuracy or money-back guarantee.
The founders
DJ
Dheeraj Jain
founderIn numbers
38labs currently · 2022
100labs target by March 2023
200labs target by March 2024
10000000lives touched
80self-owned labs
2000collection centres
1500phlebotomists
What happens next
- Reach 100 labs by March 2023 and 200 labs by March 2024.
- Expand in Tier 2, 3, and 4 towns and cities.
- Enter south India with regional labs in Tamil Nadu and Bengaluru.
- Set up 3 satellite labs each in Tamil Nadu, Karnataka, and Kerala between January and March 2023.
- Open 50 collection centres each in Tamil Nadu and Karnataka between January and March 2023.
- Target 150-200 tie-ups with doctors to open labs in their clinics in Tamil Nadu and Karnataka.
- Acquire a player in Tamil Nadu covering Madurai and Salem.
- Enter specialised testing, for which the south is the biggest market.
Earlier rounds
- 2022-05 · Series B · $61 million
The numbers around it
Redcliffe Labs has 4 funding rounds in StopDown's archive, $115 Mn raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 17 September 2024 | Series C | $42M | IFU (Denmark's Investment Fund for Developing Countries) |
| 13 August 2023 | growth | $80 million | |
| 6 May 2022 | Series B | $61M | LeapFrog Investments |
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Series B/C: Series B, C, D and later rounds are growth rounds: large cheques for a startup with a proven model that wants to expand, enter new markets or move toward profit and a listing. In India they are usually priced in CCPS and, when foreign investors take part, must follow FEMA pricing rules.
Read next
FundingRedcliffe Lifetech raises $61 million Series BRedcliffe Lifetech is an omnichannel diagnostics platform offering 3,500+ pathology and genetic testsFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on Redcliffe Labs → · All startup news on 29 September 2022 →
Is this Redcliffe Labs? Get your “Featured on StopDown” badge →